RecruitingNot ApplicableNCT06428643

A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities

A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities in Black Youth Living in the Deep South


Sponsor

Tulane University

Enrollment

2,322 participants

Start Date

Aug 14, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study includes testing for four STIs (chlamydia, gonorrhea, syphilis, and HIV) at no cost. If positive, individual subjects will also be counseled and offered options for treatment for themselves and their sex partners that may include no cost expedited treatment and the option to be rescreened 3 months after treatment.


Eligibility

Min Age: 15 YearsMax Age: 26 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Chlamydia, gonorrhea, syphilis, and HIV screening for people with chlamydia, gonorrhea, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 15 Years to 26 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERChlamydia, gonorrhea, syphilis, and HIV screening

Individuals aged 15-26 years old will be tested for chlamydia, gonorrhea, HIV, and syphilis at community based venues. Individuals who test positive for chlamydia and gonorrhea and their sexual partners will be offered expedited treatment at participating pharmacies. Individuals who test positive will be asked to be rescreened for Ct/GC at 3 months post treatment.


Locations(1)

Tulane University Celia Scott Weatherhead School of Public Health and Tropical Medicine

New Orleans, Louisiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06428643


Related Trials